Begum Alaybeyoglu, PhD (she/her/hers)

Sr. Principal Pharmacometrician
Novartis

Poster(s):

• (S-106) Clinical PK characterization of EGT710, a novel coronavirus Mpro inhibitor, and simulation of target attainment rates for efficacious dose prediction
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT